Tech Company Financing Transactions

PhaseBio Pharmaceuticals Funding Round

PhaseBio Pharmaceuticals, based in Malvern, raised $23 million in funding from Astellas Venture Capital, Fletcher Spaght Ventures and Hatteras Venture Partners.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
The funding will support Phase 2b clinical testing of Glymera for the treatment of type 2 diabetes, a Phase 1 clinical study of Vasomera in patients with stage 1 and 2 essential hypertension and additional preclinical work to support further clinical development of Vasomera for the treatment of acute and chronic heart failure and pulmonary hypertension, and to complete a Phase 1/2a clinical study of Insumera, a fully native mature insulin fused to ELP, for type 2 diabetes.

Company Information

Company Status
Mailing Address
1 Great Valley Pkwy. 30
Malvern, PA 19355
Email Address
Not Recorded
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), located in Malvern, PA, is a development stage, privately held protein engineering company focused on developing the next generation of biopharmaceuticals.
PhaseBio Pharmaceuticals LinkedIn Company Profile
Social Media
PhaseBio Pharmaceuticals Company Twitter Account
Company News
PhaseBio Pharmaceuticals News
PhaseBio Pharmaceuticals on Facebook
PhaseBio Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Jonathan Mow
  Jonathan Mow LinkedIn Profile  Jonathan Mow Twitter Account  Jonathan Mow News  Jonathan Mow on Facebook
Chief Financial Officer
John Sharp
  John Sharp LinkedIn Profile  John Sharp Twitter Account  John Sharp News  John Sharp on Facebook
Chief Medical Officer
John Lee
  John Lee LinkedIn Profile  John Lee Twitter Account  John Lee News  John Lee on Facebook
VP - Bus. Development
Susan Arnold
  Susan Arnold LinkedIn Profile  Susan Arnold Twitter Account  Susan Arnold News  Susan Arnold on Facebook
VP - Bus. Development
Michael York
  Michael York LinkedIn Profile  Michael York Twitter Account  Michael York News  Michael York on Facebook
VP - R & D
James Ballance
  James Ballance LinkedIn Profile  James Ballance Twitter Account  James Ballance News  James Ballance on Facebook



Browse more venture capital transactions:

Prev: 6/6/2012: Limeade venture capital transaction
Next: 6/6/2012: Donuts venture capital transaction


Share this article


About Database of VC Transactions

We do our best to document tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary